Histone deacetylases (HDACs) inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11535598
APP PUB NO 20210355089A1
SERIAL NO

16494284

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Histone deacetylases (HDACs) inhibitors are disclosed according to the following structural formula.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ANNJI PHARMACEUTICAL CO., LTD.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chern, Ji-Wang Taipei, TW 16 68
Ho, Yi-Hsun Taipei, TW 2 1
Huang, Chan-Hui Taipei, TW 1 1
Hung, Pei-Yun Taipei, TW 2 1
Liu, Jia-Rong Taipei, TW 1 1
Wu, Chia-Yu Taipei, TW 36 104
Yu, Chao-Wu Taipei, TW 4 21

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 27, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 27, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 27, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00